CSL Ltd (CSL)

Currency in AUD
168.30
-2.90(-1.69%)
Closed·

CSL (CSL) Earnings Dates & Reports

Latest Release
Aug 18, 2025
EPS / Forecast
2.04 / 2.70
Revenue / Forecast
7.08B / 10.2B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/20252.04/2.707.08B/10.20B-24.44%-30.61%Free Sign Up
12/20244.13/4.508.48B/8.02B-8.22%+5.75%Free Sign Up
12/2022--/3.56--/5.91B----Free Sign Up
06/2022--/1.09--/4.64B----Free Sign Up
12/2021--/3.11--/5.62B----Free Sign Up
06/2021--/1.05--/4.42B----Free Sign Up
12/2020--/2.84--/4.82B----Free Sign Up
06/2020--/1.94--/4.42B----Free Sign Up
12/2019--/2.40--/4.52B----Free Sign Up
06/2019--/1.70--/4.05B----Free Sign Up

All numbers in

CSL Ltd Earnings Call Summary for H2/2026

  • CSL reported FY26 revenue of $15.8B (down 1%) and underlying NPAT-A of $3.1B (down 2%); statutory loss of $2.6B due to $6B in restructuring charges.
  • Shares surged 16.4% to $156.68 as company guided FY27 NPAT growth of ~5% despite flat revenue; authorized new AUD 1.1B buyback program.
  • CSL Behring expected to return to mid-single-digit growth on strong immunoglobulin demand; Vifor remains major drag with ~25% revenue decline forecast.
  • Company targeting $220M incremental savings in FY27, rising to $550M by FY28; maintaining dividend at $2.92/share with strong $3.5B operating cash flow.
  • Seqirus forecast for low-single-digit growth despite soft U.S. flu market; management emphasized plasma efficiency and portfolio simplification as key priorities.
Last Updated: 08/17/2026, 09:27 PM
Read Full Transcript
CSL investor slides for H2/2026
CSL FY26 slides
Last Update: Aug 18, 2026
See full investor slides

FAQ

What Is CSL's Earnings Per Share (TTM)?

The CSL EPS (TTM) is -5.35.

What Is CSL’s Revenue Forecasts For Upcoming Quarters?

CSL’s revenue forecast is 6.087B.

How Did CSL React to the Company's Latest Earnings Report?

CSL reported a -8.22% EPS surprise and a +5.75% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -16.60%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.